Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CyNCh: Cysteamine bitartrate for pediatric NAFLD
NCT01529268Phase 3Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jun 2012
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cysteamine in non-alcoholic fatty liver disease (NAFLD), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Jun 2012; status: completed.
02
Drugs
cysteamine
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT01529268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01529268.